BDBM181133 US10093658, Compound Allopurinol::US10752613, Compound Allopurinol::US11021454, Compound Allopurinol::US9138393, Allopurinol::US9144538, Allopurinol

SMILES Oc1ncnc2[nH]ncc12

InChI Key InChIKey=OFCNXPDARWKPPY-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 181133   

TargetCytochrome P450 3A4(Human)
The Procter & Gamble

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >1.00E+4nMAssay Description:A commercially available P450-GLO Assay kit (Promega Corporation, Madison Wis.) is used to screen various compounds for CYP3A4A inhibition activity. ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 3A4(Human)
The Procter & Gamble

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >1.00E+4nMAssay Description:Cytochrome P450 is a large and diverse group of enzymes that catalyze the oxidation of organic substances. Some members of the CYP family contribute ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >3.00E+5nMAssay Description:URAT1 (SLC22A12) activity was evaluated in a cellular uptake assay using a 96-well plate with stably transfected URAT-1/CHO cells. 3H-orotate was use...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetXanthine dehydrogenase/oxidase(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50:  3.50E+3nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan M P:...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >3.00E+5nMAssay Description:URAT1 (SLC22A12) activity was evaluated in a cellular uptake assay using a 96-well plate with stably transfected URAT-1/CHO cells. 3H-orotate was use...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetXanthine dehydrogenase/oxidase(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50:  2.31E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >3.00E+5nMAssay Description:URAT1 (SLC22A12) activity was evaluated in a cellular uptake assay using a 96-well plate with stably transfected URAT-1/CHO cells. 3H-orotate was use...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetXanthine dehydrogenase/oxidase(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50:  3.5nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan M P:...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50: >3.00E+5nMAssay Description:URAT1 (SLC22A12) activity was evaluated in a cellular uptake assay using a 96-well plate with stably transfected URAT-1/CHO cells. 3H-orotate was use...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetXanthine dehydrogenase/oxidase(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50:  3.5nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan M P:...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetXanthine dehydrogenase/oxidase(Human)
Acquist

US Patent
LigandPNGBDBM181133(US10093658, Compound Allopurinol | US10752613, Com...)
Affinity DataIC50:  2.00E+3nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan M P:...More data for this Ligand-Target Pair
In DepthDetails US Patent